CytoHub

BioEngineAI

Empowering Through AI-Driven Insights

Inefficient processes and limited product knowledge are among the factors impede the ability to achieve therapeutic-grade mass production. We have developed a comprehensive knowledge library on cell and developmental biology, with applications in cell therapy and regenerative medicine, sourced from published literature and continually enhanced with proprietary data from our processes and products.

This integration of deep biological knowledge and cutting-edge AI positions us as pioneers in the development of scalable, high-quality cell therapies and regenerative medicine solutions.

We partner & adopt the best-in-class models & technology

CytoGPT™ Platform:

  • Developed in collaboration with NVIDIA, this platform utilizes AI to:

    • Auto-generate optimized protocols
    • Perform in-depth process analysis
    • Expand CMC knowledge base

BioEngineAI™ 1.0:

With BioEngineAI, you can leverage the most advanced assay technology to conduct precise analytics and gain an in-depth understanding of your cell and gene therapies. An AI-driven engine capable of recognizing and analyzing cell images and videos, enhancing process understanding and control.

Data Source

Experimental

CRISPR screens, assay data, FC, IMC, imaging

Omics

RNAseq, WGS, methylation, ATACseq

Biomanufacturing

Viability and growth assays, stability tests, pH, DO

Biological systems databases

Mechanisms, pathways, components, function, pathophysiology

Literature

Scientific, patent, regulatory

Models and Tools

Proteomic & Genomic
Knowlwdge Graphs
Data Queries
Transcriptomic
Imputation & Association Models

Building BioEngineAI

For scalable and reliable manufacturing by robust integration of experimentation and modeling

Generating Data at Scale

To power characterization and discovery through application of top-notch tools and AI/ML models

Solving Technical Challenges

With CytoHub’s AI platform and proprietary biomanufacturing solving customer’s complex technical issues